Asian Pacific Journal of Cancer Prevention

  • 제13권5호
  • /
  • Pages.2249-2252
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

MTHFR Polymorphisms and Pancreatic Cancer Risk:Lack of Evidence from a Meta-analysis

  • Li, Lei (Department of Gastroenterology, Zhongshan Hospital, Fudan University) ;
  • Wu, Sheng-Di (Department of Gastroenterology, Zhongshan Hospital, Fudan University) ;
  • Wang, Ji-Yao (Department of Gastroenterology, Zhongshan Hospital, Fudan University) ;
  • Shen, Xi-Zhong (Department of Gastroenterology, Zhongshan Hospital, Fudan University) ;
  • Jiang, Wei (Department of Gastroenterology, Zhongshan Hospital, Fudan University)
  • 발행 : 2012.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms have been reported to be associated with pancreatic cancer, but the published studies had yielded inconsistent results.We therefore performed the present meta-analysis. Methods: A search of Google scholar, PubMed, Cochrane Library and CNKI databases before April 2012 was conducted to summarize associations of MTHFR polymorphisms with pancreatic cancer risk. Assessment was with odds ratios (ORs) and 95% confidence intervals (CIs). Publication bias were also calculated. Results: Four relative studies on MTHFR gene polymorphisms (C667T and A1298C) were involved in this meta-analysis. Overall, C667T(TT vs. CC : OR = 1.61, 95%CI = 0.78 - 3.34; TT vs. CT : OR = 1.41, 95%CI = 0.88-2.25; dominant model: OR = 0.68, 95%CI = 0.40-1.17; recessive model: OR = 0.82, 95%CI = 0.52-1.30) and A1298C(CC vs. AA:OR=1.01, 95%CI=0.47-2.17; CC vs. AC: OR=0.99,95%CI=0.46-2.14; dominant model: OR=1.01, 95%CI = 0.47-2.20; recessive model: OR = 1.01, 95%CI = 0.80-1.26) did not increase pancreatic cancer risk. Conclusion: This meta-analysis indicated that MTHFR polymorphisms (C667T and A1298C) were not associated with pancreatic cancer risk.

키워드

참고문헌

  1. Boccia S, Hung R, Ricciardi G, et al (2008). Meta-and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol, 167, 505-16.
  2. Botto LD, Yang Q (2000). 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol, 151, 862-77. https://doi.org/10.1093/oxfordjournals.aje.a010290
  3. Eads CA, Nickel AE, Laird PW (2002). Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc (Min/+) Dnmt1-hypomorphic Mice. Cancer Res, 62, 1296-9.
  4. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3. https://doi.org/10.1038/ng0595-111
  5. Genkinger JM, Li R, Spiegelman D et al (2012). Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev, 21, 305-18. https://doi.org/10.1158/1055-9965.EPI-11-0945-T
  6. Jang JH, Cotterchio M, Borgida A et al (2012). Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis, 33, 818-27. https://doi.org/10.1093/carcin/bgs028
  7. Klein AP (2012). Genetic susceptibility to pancreatic cancer. Mol Carcinog, 51, 14-24. https://doi.org/10.1002/mc.20855
  8. Lam ET, Bracci PM, Holly EA, et al (2012). Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res, 72, 686-95. https://doi.org/10.1158/0008-5472.CAN-11-1682
  9. Lee JE, Wei EK, Fuchs CS, et al (2012). Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control, 23, 537-45. https://doi.org/10.1007/s10552-012-9911-3
  10. Li D, Ahmed M, Li Y et al (2005). 5, 10-methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 14, 1470-6. https://doi.org/10.1158/1055-9965.EPI-04-0894
  11. Matsubayashi H, Skinner HG, Iacobuzio-Donahue C et al (2005). Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. Clin Gastroenterol Hepatol, 3, 752-60. https://doi.org/10.1016/S1542-3565(05)00359-9
  12. National Cancer Institute, Surveillance Epidemiology and End Results. Pancreas. SEER Stat Fact Sheets. Availble from: URL: http://seer.cancer.gov/statfacts/html/pancreas.html.
  13. Nikfam S, Pourshams A(2012). A systematic review of environmental risk factors for pancreatic cancer. Govaresh, 16, 258-65.
  14. Papandreou CN, Doxani C, Zdoukopoulos N, et al (2012). Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate-gene association study in a South-eastern European population. DNA Cell Biol, 31, 193-8. https://doi.org/10.1089/dna.2011.1292
  15. Ramsey SD, Holmes RS, McDermott CL (2012). A comparison of approaches for association studies of polymorphisms and colorectal cancer risk. olorectal Dis. doi: 10.1111/j.1463-318.
  16. Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012). Folate associated with pancreatic cancer? Mol Carcinog, 51, 119-27. https://doi.org/10.1002/mc.20833
  17. Suzuki T, Matsuo K, Sawaki A et al (2008). Alcohol drinking and one-carbon metabolism-related gene polymporphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev, 17, 2742-7. https://doi.org/10.1158/1055-9965.EPI-08-0470
  18. Taioli E, Garza MA, Ahn YO, et al (2009). Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol, 170, 1207-21. https://doi.org/10.1093/aje/kwp275
  19. Wang L, Miao X, Tan W et al (2005). Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol, 3, 743-51. https://doi.org/10.1016/S1542-3565(05)00156-4
  20. Weisberg I, Tran P, Christensen B, et al (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72. https://doi.org/10.1006/mgme.1998.2714